Study Comparing 3 New Formulations of Premarin® 0.625 mg/MPA 2.5 mg With a Reference Formulation

This study has been completed.

Study NCT00630435 Information provided by Wyeth is now a wholly owned subsidiary of Pfizer

First Received: February 28, 2008 Last Updated: February 3, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2008
Primary Completion Date:	June 2008 (Final data collection date for primary outcome measure)